“Once-in-a-generation” researcher John Blenis joins the Meyer Cancer Center team as Anna-Maria and Stephen Kellen Professor of Cancer Research. Read more
A research team led by Selina Chen-Kiang has revealed key insights into why late resistance to breakthrough drug ibrutinib occurs in many mantle cell lymphoma patients, and has shown preclinical success with two new treatment strategies. Read more
Researchers at Weill Cornell Medical College have discovered what they believe may be the first effective drug therapy to prevent tongue cancer, one of the world's most common cancers. Read more
Meyer Cancer Center director Lewis Cantley has collaborated with fellow Breakthrough Prize award winners to establish a new annual life sciences award for postdocs. Read more
A $75 million gift from Sandra and Edward Meyer ’48 and the Sandra and Edward Meyer Foundation will enhance the medical college’s distinguished cancer research and care programs. Read more
Feature in Science highlights Selina Chen-Kiang’s dogged determination in her quest to resurrect the drug palbociclib for its potential in treating blood cancers. Read more